*	OR T5 T7 T6
R1	Subsumes Arg1:T4 Arg2:T5	
*	OR T2 T3
R2	Subsumes Arg1:T1 Arg2:T2	
*	OR T1 T4
R3	Has_temporal Arg1:T1 Arg2:T8	
R4	Has_temporal Arg1:T14 Arg2:T12	
R5	Has_temporal Arg1:T15 Arg2:T13	
*	OR T14 T15
R6	AND Arg1:T16 Arg2:T14	
*	OR T20 T19
R7	Has_qualifier Arg1:T18 Arg2:T19	
R8	AND Arg1:T23 Arg2:T22	
R9	AND Arg1:T22 Arg2:T24	
R10	Has_value Arg1:T21 Arg2:T23	
R11	Has_temporal Arg1:T18 Arg2:T21	
R13	Subsumes Arg1:T26 Arg2:T25	
R12	Has_qualifier Arg1:T27 Arg2:T26	
R14	Has_temporal Arg1:T27 Arg2:T29	
*	OR T31 T32
*	OR T33 T34
R15	Has_qualifier Arg1:T31 Arg2:T33	
*	OR T37 T38
R16	AND Arg1:T39 Arg2:T37	
R17	AND Arg1:T42 Arg2:T41	
*	OR T43 T44
R18	Subsumes Arg1:T43 Arg2:T47	
R19	AND Arg1:T45 Arg2:T43	
*	OR T50 T51 T52 T53
R20	Has_temporal Arg1:T54 Arg2:T55	
*	OR T57 T58 T59 T60 T61 T56
*	OR T62 T63
R22	Has_qualifier Arg1:T66 Arg2:T67	
R23	AND Arg1:T67 Arg2:T68	
*	OR T70 T71
R24	Has_qualifier Arg1:T72 Arg2:T70	
*	OR T74 T75
R25	Subsumes Arg1:T72 Arg2:T74	
R26	Has_negation Arg1:T78 Arg2:T77	
R27	Has_qualifier Arg1:T72 Arg2:T79	
R28	multi Arg1:T79 Arg2:T78	
R29	Has_temporal Arg1:T72 Arg2:T80	
R30	Has_temporal Arg1:T82 Arg2:T83	
R31	multi Arg1:T81 Arg2:T82	
R32	Has_index Arg1:T80 Arg2:T81	
R33	Has_mood Arg1:T86 Arg2:T84	
R34	Has_temporal Arg1:T86 Arg2:T85	
R35	AND Arg1:T72 Arg2:T86	
R36	Has_qualifier Arg1:T88 Arg2:T87	
R37	Subsumes Arg1:T88 Arg2:T57	
R38	Has_temporal Arg1:T92 Arg2:T93	
R39	multi Arg1:T91 Arg2:T92	
R40	Has_index Arg1:T64 Arg2:T91	
*	OR T64 T90
R21	Has_temporal Arg1:T62 Arg2:T64	
R41	Has_index Arg1:T90 Arg2:T95	
R42	Has_qualifier Arg1:T28 Arg2:T26	
R43	Has_temporal Arg1:T28 Arg2:T29	
R44	AND Arg1:T47 Arg2:T48	
T1	Drug 31 55	MF59-containing vaccines
T2	Drug 62 67	Fluad
T3	Drug 72 80	Addigrip
T4	Drug 85 118	virosome-based influenza vaccines
T5	Drug 127 137	Inflexal V
T6	Drug 140 154	InfectoVac Flu
T7	Drug 159 166	Invivac
T8	Temporal 168 205	during the 2006-2007 influenza season
T12	Temporal 244 258;317 349	within 2 weeks prior to enrolment in this study
T13	Temporal 244 250;289 296;317 349	within 4 weeks prior to enrolment in this study
T14	Drug 264 284	inactivated vaccines
T15	Drug 302 315	live vaccines
T16	Drug 226 243	licensed vaccines
T18	Drug 380 387	vaccine
T19	Qualifier 392 422	foreseen by the study protocol
T20	Negation 388 391	not
T21	Temporal 423 436	up to 30 days
T22	Drug 454 465	vaccination
T23	Value 447 453	second
T24	Drug 471 483	H5N1 vaccine
T25	Temporal 521 538	more than 14 days
T26	Qualifier 486 493	Chronic
T27	Drug 543 561	immunosuppressants
T28	Drug 565 593	other immune-modifying drugs
T29	Temporal 594 617	within six months prior
T31	Condition 696 713;733 742	immunosuppressive condition
T32	Condition 717 742	immunodeficient condition
T33	Qualifier 673 682	confirmed
T34	Qualifier 686 695	suspected
T37	Condition 840 867	chronic alcohol consumption
T38	Condition 875 885	drug abuse
T39	Temporal 829 836	History
T41	Condition 899 927	hypersensitivity to vaccines
T42	Temporal 888 895	History
T43	Condition 941 957	allergic disease
T44	Condition 941 949;961 970	allergic reactions
T45	Temporal 930 937	History
T47	Condition 1039 1042;1058 1065	egg allergy
T48	Condition 1047 1065	thiomersal allergy
T51	Condition 1109 1123;1142 1164	cardiovascular functional abnormality
T52	Condition 1125 1132;1142 1164	hepatic functional abnormality
T53	Condition 1136 1164	renal functional abnormality
T50	Condition 1098 1107;1142 1164	pulmonary functional abnormality
T54	Condition 1236 1249	Acute disease
T55	Temporal 1250 1274	at the time of enrolment
T56	Condition 1337 1354;1418 1426	chronic pulmonary disorder
T57	Condition 1337 1344;1356 1370;1418 1426	chronic cardiovascular disorder
T58	Condition 1337 1344;1372 1377;1418 1426	chronic renal disorder
T59	Condition 1337 1344;1379 1391;1418 1426	chronic neurological disorder
T60	Condition 1337 1344;1393 1404;1418 1426	chronic psychiatric disorder
T61	Condition 1337 1344;1408 1426	chronic metabolic disorder
T62	Drug 1506 1521	immunoglobulins
T63	Drug 1529 1547	any blood products
T64	Temporal 1548 1603	within the three months preceding the first vaccination
T66	Condition 1821 1830	condition
T67	Qualifier 1831 1836;1874 1926	which prevents the subject from participation in the study
T68	Non-representable 1838 1872	in the opinion of the investigator
T69	Non-representable 1817 1927	Any condition which, in the opinion of the investigator, prevents the subject from participation in the study.
T70	Qualifier 1637 1652	investigational
T71	Qualifier 1656 1670	non-registered
T72	Drug 1671 1678	product
T74	Drug 1680 1684	drug
T75	Drug 1688 1695	vaccine
T77	Negation 1697 1707	other than
T78	Drug 1712 1728	study vaccine(s)
T79	Qualifier 1697 1728	other than the study vaccine(s)
T80	Temporal 1729 1774	within 30 days prior to the first vaccination
T81	Reference_point 1753 1774	the first vaccination
T82	Procedure 1763 1774	vaccination
T83	Temporal 1757 1762	first
T84	Mood 1779 1786	planned
T85	Temporal 1791 1814	during the study period
T86	Procedure 1787 1790	use
T87	Qualifier 1277 1284	Serious
T88	Condition 1285 1300	chronic disease
T90	Temporal 1607 1623	during the study
T91	Reference_point 1582 1603	the first vaccination
T92	Procedure 1592 1603	vaccination
T93	Temporal 1586 1591	first
T95	Reference_point 1614 1623	the study
